Oxford Immunotec Global PLC (OXFD -9.8%) is down, albeit on below-average volume, after releasing Q1 results that came in shy of expectations.
The company said that COVID-19 headwinds “became
apparent” near quarter-end and it expects a $5M – 6M drop in Q2
revenues, adding that it anticipates this quarter to experience the most
significant disruptions from the pandemic. Citing the uncertainty
related to the scope and duration of the contagion, it is unable to
provide annual revenue guidance.
https://seekingalpha.com/news/3569160-soft-outlook-pressures-oxford-immunotec-shares-down-10
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.